Medicare Coverage for Cancer: 2025 Complete Guide

Cancer is the second leading cause of death in the United States, and Medicare is the primary insurer for most Americans who face a cancer diagnosis after age 65. This guide explains exactly what Medicare covers, the critical difference between oral and IV chemotherapy costs, how the 2025 $2,000 Part D cap changes the financial picture for many patients, and what gaps remain.

Medicare Cancer Coverage: Quick Reference by Part

The Oral vs. IV Chemotherapy Gap: A Critical Cost Difference

This is the single most important financial distinction for cancer patients using Medicare — and it surprises many people at the worst possible time.

When chemotherapy is administered intravenously (IV) by a healthcare provider in an outpatient setting, it's covered under Part B. You pay 20% coinsurance. With Medigap Plan G, that 20% is covered, meaning IV chemo costs you nothing beyond the Part B deductible.

When chemotherapy is taken as a pill, capsule, or tablet at home, it falls under Part D — your prescription drug plan. Before 2025, this created enormous cost differences: a patient on oral chemo might pay thousands per month while a patient on IV chemo paid nothing.

The good news: starting January 2025, the $2,000 annual out-of-pocket cap applies to all Part D drugs, including oral chemotherapy. Once you've spent $2,000 on covered Part D drugs in a year, you pay $0 for the rest of that year. This is a meaningful improvement — but the structural divide between Part B and Part D for cancer drugs still exists.

Examples of Oral vs. IV Classification

Cancer Screenings Covered at No Cost

Medicare covers these cancer screenings as preventive services — meaning no deductible or coinsurance applies when you use a participating provider:

The 20% Coinsurance Problem — and How to Solve It

Original Medicare's 20% coinsurance for Part B services has no annual cap. For cancer patients receiving expensive infused therapies, this can become catastrophic:

• A monthly Keytruda infusion at $17,000/dose × 20% = $3,400/month out of pocket
• A course of Avastin at $9,000/infusion × 20% = $1,800 per infusion
• A year of Rituxan treatments can cost $7,000–$15,000 in 20% coinsurance alone

The solution: Medigap Plan G. Plan G covers all Part B coinsurance after the $257 annual deductible. With Plan G, those infused chemotherapy costs would be $0 beyond the deductible. This is why Plan G is widely considered the most important financial protection tool for cancer patients on Medicare.

For oral chemotherapy under Part D, the $2,000 annual out-of-pocket cap (effective 2025) provides comparable protection on the drug side.

Medicare Advantage and Cancer: What to Know

Medicare Advantage plans cover the same cancer treatments as Original Medicare, but the cost structure and access can differ significantly:

• Prior authorization: MA plans frequently require prior authorization for chemotherapy regimens, infusion drugs, and hospitalizations. Denials can delay care.
• Network restrictions: Major cancer centers (MD Anderson, Memorial Sloan Kettering, Mayo Clinic) may not be in-network for your MA plan. Out-of-network costs can be substantial.
• Out-of-pocket maximum: MA plans cap costs at $9,350/year in-network (2025). Original Medicare has no cap — making Medigap Plan G the better protection for people with high-cost treatments.
• Specialist referrals: HMO-type MA plans require referrals from a primary care physician to see oncologists.

Many oncologists and cancer advocacy organizations recommend Original Medicare + Medigap Plan G for people with active cancer or high cancer risk, specifically because of the freedom to access any Medicare-accepting provider without prior authorization delays.

What Medicare Does NOT Cover for Cancer

• Custodial or personal care: Help with bathing, dressing, or daily activities during treatment is not covered (unless you qualify for home health under Part A/B).
• Experimental treatments: Treatments not approved by the FDA and not covered under a Medicare-approved clinical trial are not covered. However, routine costs of care within approved clinical trials are covered.
• Transportation to treatment: Rides to chemotherapy or radiation appointments are not covered under Original Medicare (some MA plans offer transportation benefits).
• Wigs for chemotherapy hair loss: Not covered.
• Dental care related to treatment: Oral care needed before head/neck radiation is not covered by Original Medicare (some MA plans cover it).
• Long-term care / skilled nursing beyond 100 days: Post-cancer skilled nursing care beyond 100 days per benefit period is not covered.

Clinical Trials: An Important Coverage Pathway

Medicare covers the routine costs of care for beneficiaries enrolled in qualifying clinical trials, even if the investigational treatment itself isn't covered. "Routine costs" include hospital stays, lab tests, imaging, and physician visits required by the trial protocol. This can provide access to cutting-edge cancer treatments while Medicare covers the associated care costs.

Cost-Saving Strategies for Cancer Patients

1. Get Medigap Plan G before your diagnosis becomes known — once you have a cancer diagnosis, Medigap may become unavailable or extremely expensive in most states. The 6-month guaranteed issue window when you turn 65 is your best opportunity.
2. Use the $2,000 Part D cap to your advantage — if you're on oral chemotherapy, you'll likely hit the $2,000 cap early in the year. The Medicare Prescription Payment Plan (M3P) lets you spread those first-of-year costs across 12 monthly installments.
3. Check drug manufacturer assistance programs — many pharmaceutical companies offer copay assistance programs even for Medicare patients using their oncology drugs.
4. Request Medicare-covered clinical trial enrollment — if standard treatments have been exhausted, a clinical trial provides access to new therapies with Medicare covering routine costs.
5. Apply for Extra Help (LIS) if you have limited income and resources — this reduces Part D costs dramatically and applies to oral chemotherapy drugs.
6. Verify network coverage at your cancer center — if you're in Medicare Advantage, confirm your preferred cancer center is in-network before beginning treatment. Switching to Original Medicare mid-treatment is possible but complex.

Frequently Asked Questions